• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Generation Bio Co. - Common stock (NQ:GBIO)

5.340 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Generation Bio Co. - Common stock

< Previous 1 2 Next >
News headline image
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
February 09, 2026
Generation Bio Stockholders Received $4.2913 Per Share in Cash Plus a Contingent Value Right 
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer
February 04, 2026
From NodThera
Via GlobeNewswire
News headline image
NodThera Appoints Geoff McDonough, M.D., as Independent Board Member
December 16, 2025
Seasoned physician-executive with global biopharma leadership experience joins Board at a pivotal stage of clinical and corporate development 
From NodThera
Via GlobeNewswire
News headline image
GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders
December 15, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
XOMA Royalty Enters into Agreement to Acquire Generation Bio
December 15, 2025
From Generation Bio Co.; XOMA Royalty Corporation
Via GlobeNewswire
News headline image
Generation Bio Announces Third Quarter 2025 Financial Results
November 05, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces CEO Transition
October 22, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
August 12, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces 1-for-10 Reverse Stock Split
July 18, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
July 07, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
May 28, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
May 07, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
April 02, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
March 13, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
February 24, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
January 06, 2025
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results
November 06, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
October 22, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
September 12, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Second Quarter 2024 Financial Results
August 07, 2024
Cash balance of $217 million still expected to fund operations into 2H 2027 
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
June 14, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
May 13, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
May 09, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
February 27, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From Generation Bio Co.
Via GlobeNewswire
News headline image
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
November 29, 2023
From Generation Bio Co.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap